Evolus (EOLS) Total Debt Growth (1y) (2018 - 2026)
Evolus (EOLS) Total Debt Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -0.14% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 37.52% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -92.65% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -9.19% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 0.63% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Evolus | 435.45 Mn | 385.65 Mn | 48.90 Mn | 28.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.41% |
| Dec 31, 2025 | 20.24% |
| Sep 30, 2025 | 20.27% |
| Jun 30, 2025 | 20.31% |
| Mar 31, 2025 | 0.97% |
| Dec 31, 2024 | 0.95% |
| Sep 30, 2024 | 27.46% |
| Jun 30, 2024 | 27.51% |
| Mar 31, 2024 | 67.44% |
| Dec 31, 2023 | 67.45% |
| Sep 30, 2023 | 32.61% |
| Jun 30, 2023 | 32.54% |
| Mar 31, 2023 | 0.93% |
| Dec 31, 2022 | 0.92% |
| Dec 31, 2021 | -4.25% |
| Dec 31, 2020 | 1.19% |
| Sep 30, 2020 | 1.08% |
| Jun 30, 2020 | 1.79% |
| Mar 31, 2020 | -74.89% |
| Dec 31, 2019 | 334.86% |